STAT3 and hepatocellular carcinoma: Additionally, this research demonstrates that CKLF1 mediated its oncogenic effects through the IL-6/STAT3 signaling pathway and could assist in the staging and prognostic assessment of patients with hepatocellular carcinoma (74).